Skip to main content
SpringerLink
Log in

'Pay for delay' settlements still occurring, says US FTC

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Hopkins Tanne J.US branded drug makers pay to prevent generic competition. BMJ 336: 1266-1267, No. 7656, 7 Jun 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

'Pay for delay' settlements still occurring, says US FTC. Pharmacoecon. Outcomes News 555, 6 (2008). https://doi.org/10.2165/00151234-200805550-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805550-00008

Keywords

Search

Navigation